Advisor Group Holdings, Inc. Journey Medical Corp Transaction History
Advisor Group Holdings, Inc.
- $39.8 Billion
- Q4 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Journey Medical Corp stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 3,677 shares of DERM stock, worth $18,973. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,677
Previous 2,979
23.43%
Holding current value
$18,973
Previous $16,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding DERM
# of Institutions
39Shares Held
2.93MCall Options Held
0Put Options Held
0-
B. Riley Securities, Inc. Los Angeles, CA865KShares$4.46 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA325KShares$1.68 Million0.0% of portfolio
-
Cambridge Investment Research Advisors, Inc.314KShares$1.62 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny268KShares$1.38 Million0.0% of portfolio
-
American Financial Group Inc180KShares$928,8000.44% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $59.8M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...